Posts Tagged 'Pfizer'

Pfizer Pays $450 Million to Settle Unlawful Marketing Claims

Patient safety is greatly compromised when financial incentives interfere with crucial medical decisions. The Wall Street Journal reports how two pharmaceutical sales representatives exposed unlawful marketing practices regarding the immunosuppressant drug, Rapamune.

Pfizer and its subsidiary, Wyeth Pharmaceuticals faced a lawsuit under the Federal False Claims Act for actively marketing Rapamune for non-FDA-approved uses as well as paying kickbacks to prescribers.

In paying kickbacks to physicians, pharmaceutical companies manipulate honest and helpful medical advice. This practice could influence a doctor’s ...

continue reading...

FDA Warns of Strong Risk of Death with Pfizer’s Drug Tygacil

The antibacterial drug Tygacil carries a higher risk of death than other drugs of its kind, an article by Reuters reports.

The U.S. Food and Drug Administration issued a safety announcement on September 27, 2013 approving a new Black Box Warning, the strongest warning that can be given to a drug, as well as updated Warnings and Precautions and Adverse Reactions portions of the drug label.

The FDA states on their website ...

continue reading...

Health warnings issued for cholesterol drugs

In a study published in Annals of Internal Medicine, Canadian researchers are advising doctors to avoid ordering certain antibiotics for patients taking the cholesterol-lowering drugs known as statins, which include Lipitor.

An article in U.S. News and World Report says statins don’t mix well with the antibiotics clarithromycin or erythromycin.

This isn’t the first time that health concerns have been raised about statins. The U.S. Food and Drug Administration has added warnings to ...

continue reading...

Diet changes an option for Lipitor users

An ABC News report asks the question of whether America is an “overmedicated nation,” and offers alternatives to some of the most commonly prescribed medications.

Among those medications are the anti-cholesterol drugs known as statins. According to the report, the pharmacies fill more than 45 million prescriptions a year for the statin known as Lipitor alone.

But recent research indicates that statins may carry some health risks. The U.S. Food and Drug Administration ...

continue reading...

Pfizer selling Irish manufacturing factory

A story in the Irish Independent says Pfizer intends to sell one of its Irish plants, in large part because of declining revenues from its anti-cholesterol drug Lipitor.

Sales of Lipitor, a former blockbuster for the company, have been plummeting recently because its patent expired, opening it up to competition from generics. The drug has also been the subject of some recent health concerns.

The U.S. Food and Drug Administration has added warnings ...

continue reading...

EU Doctors urge caution when prescribing Lipitor

Some European medical professionals are urging their colleagues to use caution in prescribing the class of cholesterol-lowering drugs known as statins, following reports linking the medications to a higher risk of diabetes.

In a study published in the British Medical Journal, Canadian researchers said powerful statins such as Lipitor may increase the risk of Type 2 diabetes by 22 percent compared with weaker drugs. The researchers analyzed a sample of 1.5 million ...

continue reading...
Page 4 of 9 «...23456...»